Adult Dosing

Nausea and upset stomach

• 1-2 tablespoons [15-30 mL] PO q15 minutes till symptoms subside
• Max: 5 doses/hr

• Do not dilute with other fluids
• Avoid fluid intake immediately before or after administration

Pediatric Dosing

• Safety and effectiveness in pediatric patients <2 yrs have not been established

Nausea and upset stomach

• 2-12 yrs
• 1-2 teaspoons [5-10 mL] PO q15 minutes till symptoms subside
• Max: 5 doses/hr

• >12 yrs
• 1-2 tablespoons [15-30 mL] PO q15 minutes till symptoms subside
• Max: 5 doses/hr

• Do not dilute with other fluids
• Avoid fluid intake immediately before or after administration

• Relief of upset stomach associated with nausea due to overindulgence in food and drink

• Hypersensitivity to any of the ingredients of the product
• Hereditary fructose intolerance (HFI)

• N/A

Renal Dose Adjustments

• Renal impairment: Dose adjustments not defined, caution advised

Hepatic Dose Adjustments

• Hepatic impairment: Dose adjustments not defined, caution advised

See Supplemental Patient Information

• Because the product contains fructose, it should not be given to patients with hereditary fructose intolerance (HFI)
• This product contains sugar and should be avoided in diabetic patients except under medical advice and supervision
• For maximum effectiveness, avoid fluid intake immediately before or at least 15 minutes after administration and avoid dilution with other fluids
• Discontinue therapy and consult a physician if symptoms persist, recur, or worsen

Cautions: Use cautiously in

• Diabetes mellitus
• Renal impairment
• Hepatic impairment

Supplemental Patient Information

• Advise patients to keep the medication out of reach of children
• Advise patients to seek medical help or contact a poison control center in case of overdose
• Advise patients who are pregnant or nursing to consult their physician before use

Pregnancy Category:NR

Breastfeeding: Safety unknown. Manufacturer advises nursing women to consult their physician before use

• GI: Diarrhea, abdominal pain, flatulence

• Antiemetic; precise mechanism of action unknown, possibly reduces contraction of GI smooth muscle
• Metabolism: Unknown
• Excretion: Unknown
• Half-life: Unknown

US Trade Name(s)

• Emetrol

US Availability

Emetrol

• OTC SOLN: 118 mL

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

Gastrointestinal

Antiemetics

Miscellaneous Agents